Metabolism - Clinical and Experimental
Volume 58, Issue 1 , Pages 93-101, January 2009

Impaired endothelial function and insulin action in first-degree relatives of patients with type 2 diabetes mellitus

  • Mette P. Sonne

      Affiliations

    • Department of Biomedical Sciences, Section of Systems Biology Research, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark
    • Corresponding Author InformationCorresponding author. Tel.: +45 3532 7421; fax: +45 35327420.
  • ,
  • Lise Højbjerre

      Affiliations

    • Department of Biomedical Sciences, Section of Systems Biology Research, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark
  • ,
  • Amra C. Alibegovic

      Affiliations

    • Steno Diabetes Center, 2820 Gentofte, Denmark
  • ,
  • Allan Vaag

      Affiliations

    • Steno Diabetes Center, 2820 Gentofte, Denmark
  • ,
  • Bente Stallknecht

      Affiliations

    • Department of Biomedical Sciences, Section of Systems Biology Research, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark
  • ,
  • Flemming Dela

      Affiliations

    • Department of Biomedical Sciences, Section of Systems Biology Research, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark

Received 14 May 2008; accepted 14 August 2008.

Abstract 

First-degree relatives (FDR) of patients with type 2 diabetes mellitus are at increased risk of developing type 2 diabetes mellitus. We studied if endothelial dysfunction of the resistance vessels is present and may coexist with metabolic insulin resistance in FDR. Male FDR (n = 13; 26 ± 1 years; body mass index, 25 ± 1 kg m2 [mean ± SEM]) and matched control subjects (CON) (n = 22; 25 ± 1 years; body mass index, 24 ± 1 kg m2) were studied by hyperinsulinemic (40 mU min−1⋅m−2) isoglycemic clamp combined with brachial arterial and deep venous catheterization of the forearm. Forearm blood flow (FBF) was measured by venous occlusion plethysmography upon stimulation with systemic hyperinsulinemia (291 ± 11 pmol/L, pooled data from both groups) and upon intraarterial infusion of adenosine (ADN) and acetylcholine (ACH) ± hyperinsulinemia. Forearm blood flow response to ADN and ACH was less in FDR vs CON (P < .05); systemic hyperinsulinemia added to the FBF effect of ADN in CON (P < .05) but not in FDR. In addition, FDR demonstrated impaired FBF to hyperinsulinemia (2.1 ± 0.2 vs 4.0 ± 0.6 mL 100 mL−1 min−1) in FDR and CON, respectively (P < .05). Both M-value (5.0 ± 0.7 vs 7.0 ± 0.5 mg min−1 kg−1) and forearm glucose clearance (0.6 ± 0.1 vs 1.4 ± 0.4 mL 100 mL−1⋅min−1) were diminished in FDR compared with CON (all P < .05). FDR demonstrated endothelial dysfunction of the resistance vessels in addition to impaired insulin-stimulated increase in bulk flow. Moreover, FDR demonstrated whole-body insulin resistance as well as decreased basal and insulin-stimulated forearm glucose uptake. It remains to be established whether FDR also demonstrate impaired insulin-stimulated microvascular function.

 

PII: S0026-0495(08)00325-9

doi:10.1016/j.metabol.2008.08.011

Metabolism - Clinical and Experimental
Volume 58, Issue 1 , Pages 93-101, January 2009